- Global Pharma News & Resources

Insights on the Lab Automation in Genomics Global Market to 2026 - Automated Liquid Handlers to Witness High Growth -

DUBLIN--(BUSINESS WIRE)--The "Lab Automation in Genomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to's offering.

The Global Lab Automation in the Genomics market is expected to grow at a CAGR of 7.5% over the forecast period (2021-2026).

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation / Beckman Coulter
  • Hudson Robotics, Inc.
  • Becton, Dickinson and Company
  • Synchron Lab Automation
  • Agilent Technologies Inc.
  • Siemens Healthineers AG
  • Tecan Group Ltd
  • Perkinelmer Inc.
  • Honeywell International
  • Eppendorf AG

Key Market Trends

Automated Liquid Handlers to Witness High Growth

  • Cross contamination is a major problem in the genomics laboratory, which can be avoided by implementing automated systems to manage the reagents and reaction mixtures. It is believed that taking out human intervention helps in achieving more consistency.
  • Many technological advances have been made in the molding of plastics that reduced the volumes of reagents used and enabled the easy handling of smaller liquid volumes. These advancements have worked in favor of the development of micro- and nano-litre plates, to fit with the automated liquid handling equipment.
  • Leading companies have set the benchmark for the development of automated liquid handlers. These companies are constantly investing in developing premium products, to increase the productivity of the process.
  • According to the Robotics Industries Association, the life science sector has the third-highest growth in industrial robots, in terms of automated liquid handlers, automated plate handlers, and robotic arms, among others to meet up the demand.

North America Occupies the Largest Market Share

  • North America has been a pioneer in clinical research for years. This region is home to some major pharmaceutical companies, like Pfizer, Novartis, GlaxoSmithKline, J&J, and Novartis. The region also has the highest concentration of contract research organizations (CROs). Some of the significant CROs are Laboratory Corp. of America Holdings, IQVIA, Syneos Health, and Parexel International Corp. Owing to the presence of all the major players in the industry and stringent FDA regulations, the market is very competitive in the region. To gain an advantage over competitors, the genomics research organizations in the region are increasingly adopting robotics and automation in labs.
  • The genomic industry, especially in the United States, is still in its growing phase and is expected to grow at a fast pace over the coming years. The availability of new genome sequencing technologies, well-established healthcare infrastructure, and the increasing geriatric population are significant contributing factors to revenue growth. In the United States, the need to accommodate growth and the drive to boost efficiency are priming blood centers to acquire fully automated walkaway systems, either to perform types and screens or to test specimens for infectious diseases.
  • Many companies are involved in innovation due to their extensive R&D capabilities. For instance, In January 2020, Benchling, a life sciences R & D cloud platform, announced the launch of its software for Lab Automation. This new solution would help life sciences companies maximize their lab automation investments.
  • The spread of COVID-19 has positively impacted the market. When COVID-19 started in the United States, scientists at the Broad Institute, affiliated with Harvard University and Massachusetts Institute of Technology, realized its genome-reading machines could be repurposed to test patient samples for the coronavirus that causes the disease. The company Color Genomics, best known for at-home genetic testing for disease risk genes, has also launched a high-throughput, CLIA-certified COVID-19 testing lab.

Key Topics Covered:





4.1 Market Overview

4.2 Industry Attractiveness - Porter's Five Forces Analysis

4.2.1 Threat of New Entrants

4.2.2 Bargaining Power of Buyers/Consumers

4.2.3 Bargaining Power of Suppliers

4.2.4 Threat of Substitute Products

4.2.5 Intensity of Competitive Rivalry

4.3 Market Drivers

4.3.1 Growing Trend of Digital Transformation for Laboratories with IoT

4.3.2 Effective Management of the Huge Amount of Data Generated

4.4 Market Restraints

4.4.1 Expensive Initial Setup

4.5 Impact of COVID-19 on the Lab Automation Market


5.1 By Equipment

5.1.1 Automated Liquid Handlers

5.1.2 Automated Plate Handlers

5.1.3 Robotic Arms

5.1.4 Automated Storage and Retrieval Systems (AS/RS)

5.1.5 Vision Systems

5.2 By Geography

5.2.1 North America

5.2.2 Europe

5.2.3 Asia-Pacific

5.2.4 Rest of the World


6.1 Company Profiles

6.1.1 Thermo Fisher Scientific Inc.

6.1.2 Danaher Corporation / Beckman Coulter

6.1.3 Hudson Robotics, Inc.

6.1.4 Becton, Dickinson and Company

6.1.5 Synchron Lab Automation

6.1.6 Agilent Technologies Inc.

6.1.7 Siemens Healthineers AG

6.1.8 Tecan Group Ltd

6.1.9 Perkinelmer Inc.

6.1.10 Honeywell International

6.1.11 Eppendorf AG



For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 11-Feb-2021